STOCKHOLM (Reuters) -Danish drugmaker Novo Nordisk will invest 8.5 billion crowns ($1.20 billion) in a new facility in Odense ...

Danish drugmaker Novo Nordisk will invest 8.5 billion crowns ($1.20 billion) in a new facility in Odense, Denmark, for the ...

Danish drugmaker Novo Nordisk will invest 8.5 billion crowns ($1.20 billion) in a new facility in Odense, Denmark, for the ...

The pharmaceutical company will establish a production facility in Odense to accommodate multiple product types within the ...

Denmark’s biggest pension fund, ATP, is taking a major hit on its 2.3 billion-krone ($324 million) stake in troubled battery ...

Denmark’s preliminary tax statements or ‘forskudsopgørelse’ for 2024 have now been available to taxpayers online for around a ...

Danish healthcare firm Novo Nordisk announced plans on Monday for new investment in a production facility in one of the ...

Ozempic maker Novo Nordisk A/S is investing 8.5 billion kroner ($1.2 billion) to build a new major factory in Denmark to help ...

Danish pharmaceutical giant Novo Nordisk, maker of diabetes and weight-loss treatments Ozempic and Wegovy, which have gained ...

Concession payments from offshore wind tenders were supposed to part-finance transmission link from planned Bornholm energy ...

Bavarian will transfer the technology to Serum Institute to supply the shots for Indian market. Serum Institute will also ...